Introduction
Brand name: Astrigine‑100 DT
Manufacturer: Astemax Biotech
Composition: Lamotrigine 100 mg dispersible tablet
Astrigine‑100 DT is the higher‑strength variant of the same brand, containing lamotrigine 100 mg per dispersible tablet. It is indicated for the same conditions as Astrigine‑50 DT:
Epilepsy (adjunctive or monotherapy for partial‑onset and generalised tonic‑clonic seizures).
Bipolar I disorder (maintenance/mood‑stabilisation therapy in adults).
Key points for Astrigine‑100 DT
Used when patients require higher daily lamotrigine doses (e.g., 200–400 mg/day), allowing fewer tablets per day while retaining the dispersible‑dose‑flexibility advantage.
Dosing: Once‑daily or twice‑daily, depending on titration and indication; start low and escalate slowly (per standard lamotrigine protocols) to minimise risk of serious skin reactions (SJS/TEN) and other adverse effects.
- Astemax can market Astrigine‑100 DT as a convenient, higher‑dose, dispersible lamotrigine option for long‑term seizure and bipolar‑mood‑control regimens, improving patient compliance and simplifying high‑dose therapy.
